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ABSTRACT
Purpose: To evaluate liver alterations caused by biliary obstruction and drainage. Methods:  Thirty-nine male Wistar rats
were randomly distributed in 4 groups: BO (n=18) bile duct ligation for 20 days, with a periodic evaluation of liver
histological alterations, Doppler echography portal flow and measurements of NO and malondialdehyde (MDA); BO/DB
(n=13) bile duct occlusion for 20 days followed by biliary drainage by choledochoduodenal anastomosis, 5 days follow-
up, same BO group parameters evaluations; group CED (n=4) sham operation and portal flow evaluation trough 20 days;
CHB (n=4) sham operation, with hepatic biopsy on 25th day and followed-up trough 25 days, by the same parameters of
group BO, with exception of portal flow. Direct bilirubin (DB) and alkaline phosphatase (AP) were evaluated in the group
BO, BO/DB and CHB.  Results: The bile duct ligation led to an increase of DB and AP, development of liver histological
alterations, reduction of portal flow and increase of plasmatic NO and of MDA levels. The bile duct clearing resulted in a
reduction of DB, AP, NO, MDA histological alterations and increase of portal flow. Conclusion: The biliary occlusion
resulted in cholestasis and portal flow reduction, besides the increase of plasmatic NO and of hepatic MDA levels, and
histological liver alterations, with a tendency of normalization after the bile duct clearing.
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RESUMO
Objetivo: Avaliar alterações hepáticas resultantes do processo de obstrução/desobstrução biliar. Métodos: Trinta e nove
ratos Wistar foram distribuídos aleatoriamente em 4 grupos: OB (n=18), oclusão biliar, seguimento de 20 dias, avaliação das
alterações histológicas hepáticas, do fluxo portal e dosagens de NO e de malondialdeído (MDA); grupo OB/DB (n=13)
oclusão biliar por 20 dias seguida de desobstrução biliar por anastomose colédoco-duodenal, seguimento por 5 dias e
avaliação dos mesmos parâmetros do grupo BO; grupo CED (n=4) operação simulada, avaliação do fluxo portal e seguimento
por 25 dias; grupo CHB (n=4) operação simulada com biópsia hepática no 25o dia, e seguido por 25 dias com avaliação
periódica dos mesmos parâmetros do grupo BO, com exceção da ecografia Doppler. Nos grupos BO, OB/DB e CHB foram
avaliadas também a bilirrubina direta (BD) e a fosfatase alcalina (FA). Resultados: A oclusão do colédoco causou aumento
da BD e da FA, desenvolvimento de alterações hepáticas, redução do fluxo portal, com aumentos do NO plasmático e do
MDA. A desobstrução biliar resultou na redução da BD, da FA, das alterações hepáticas, aumento do fluxo portal e
redução do NO e do MDA. Conclusão: A obstrução biliar resultou em colestase, alterações histológicas hepáticas,
diminuição do fluxo portal, aumentos do NO plasmático e MDA hepático, com tendência à normalização após a desobstrução
biliar.
Descritores: Fígado. Fluxo Portal. Óxido Nítrico. Obstrução Biliar. Colestase. Peroxidação Lipídica. Malondialdeido.
1. Work performed at the Department of Surgery and Anatomy, Ribeirão Preto Faculty of Medicine, University of São Paulo, Brazil.
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Introduction
Benign extra-hepatic cholestasis may lead to
cholangitis and increased intra-canaliculi pressure,
developing acute and chronic hepatic injuries1,2 reduced
portal flow,3-6 increased serum nitric oxide (NO)7-9 and
triggering of liver lipid peroxidation.10-12 Surgical
desobstruction is the elective treatment.
Acute liver injuries results, among others, mainly
in abscesses, ductal proliferation and reduced number of
hepatocyte2 while secondary biliary cirrhosis is aroused
due to chronic injuries.13 Portal flow may be reduced up to
50% in 7 days.6 Quantitative and qualitative alterations of
the free radicals (FR) enzymes, constitutive NO isoforms
(cNOS)14,15 and the presence of inducible isoform (iNOS)
following the outcome of inflammatory process9 promotes
increases of NO concentration. The accumulation of
hydrophobic bile acids during cholestasis leads to
mitochondrial FR generation in the liver, consisting of a
major mechanism of injury and fibrosis due to the
propagation of the lipid peroxidation chain after
spontaneous reaction with oxygen.11,16,17
Histological injuries reduced portal flow, increased
plasma NO and liver lipid peroxidation associated with extra-
hepatic cholestasis are events reported by pertinent
literature in a isolated manner.
The proposal of this study is to evaluate the above
parameters simultaneously in the same experimental model.
New investigations are worthwhile to better understand the
relation between the aggravating factors of extra-hepatic
cholestasis, especially NO and portal flow.
Methods
Twenty six male Wistar rats, weight range 230 e 370
g, were randomly distributed into 3 groups. Group 1: Biliary
Occlusion (BO), n=18, submitted to biliary occlusion after
sectioning and ligature of choledoch duct. Doppler
echography were performed on days 0, 15 and 20 to evaluate
portal flow and obtain liver biopsy, whereby 650 and 900
mg pieces were removed for histology and for dosage of
NO and malondialdehyde (MDA). Simultaneously, blood
was collected from the inferior cava vein for dosage of NO,
direct bilirubin (DB) and alkaline phosphatase (AP). Hepatic
tissue histology and morphometry were done with biopsy
fragments obtained during sacrifice. Group 2: Simulated
biliary obstruction as control of portal flow through Doppler
echography, (CED), n=4, submitted to biliary simulated
obstruction as control for Doppler echography, performed
on days 0, 15 and 20. Group 3: Simulated biliary obstruction
as control for histology and biochemical dosages, (CHB),
n=4, submitted to simulated biliary obstruction and
afterwards to hepatic biopsy for dosage of NO and MDA
and blood withdrawal on days 0, 15 and 20.
Surgical procedure: After 12 hours of fasting and
water ad libitum, the animals were anesthetized by ethyl
ether inhalation. Group BO: xiphopubic median laparotomy,
acknowledge and distal ligature of choledochus, biopsy
pieces removed from the left lobe of the liver on day 0, from
the right lobe on day 15 and again left lobe on day 20 with
posterior suture. Collection of 2.5 mL of blood from the
inferior cava vein. Careful and meticulous hemostasis and
abdominal closure in two planes. Groups CED and CHB
were submitted to simulated surgery (Figure 1).
FIGURE 1    -        a) Blood collection from inferior cava vein,
b) Double ligature of choledochus,
c) Delimitating suture of the hepatic area
where biopsy is performed and
d) Visualization of the dilated choledochus
adjoining to the duodenum.
Histology: Hematoxylin-eosin stain was employed
and hepatic tissue morphometry was performed by the
evaluation of the volume fractions calculated from the
fraction of points overlaying a specific compartment divided
by the total number of points counted, which was calculated
for hepatocytes, fibroblasts, fibrosis, biliary ducts, blood
vessels and inflammatory cells contained in the hepatic
tissue.
Direct Bilirubin (DB) and alkaline phosphatase
(AP): were determined respectively, by the SIMS & HORN
(1958) and ROY (1970) colorimetric method.
Portal Flow: Coloured and spectral Doppler,
portable equipment, model LOGIQ Book, GE Medical
Systems, with multifrequencies (5 a 10 MHz) linear electronic
transducer, EEUU.
Plasma Nitric Oxide (NO): Indirect determination
trough dosage of nitrate by the Sievers NO Analizer, EEUU;
tissular: indirect determination through dosage of nitrate
by Griess solution.
Malondialdehyde (MDA): measurements
performed by specific kit with methodology described by
BUEGE and AUSSI (1978).
Statistical analysis: To compare statistical
significance within groups analysis of variance (ANOVA)
test was used. Between groups, two-way ANOVA was
applied. Comparative analysis was made using Friedman
test for each group and Kruskal-Wallis and Mann-Whitney
for each day. The morphometric evaluation was analyzed
using the X²-test for binomial proportions of some
characteristics presented in the animals.
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Results
Histology: Microscopic evaluation of the hepatic
tissue in group BO revealed reduced number of hepatocytes,
as well as ductal proliferation, vascular neoformation,
inflammatory cells, fibrosis and apoptotic corpuscles. On
the other hand, control had no unexpected findings.
Morphometric analysis performed by the X2-test shows
significant difference to hepatocytes, fibroblasts, fibrosis,
ducts and inflammatory cells (Figure 2).
FIGURE 2 -     Morphometric evaluation of hepatic tissue.
Data is presented as mean. p<0,001 for group
BO (20 days) versus group BO/DB (25 days).
Direct bilirubin: Analysis within group
demonstrated in group BO significant difference between
basal value and days 15 (p=0,016) and 20 (p=0,02). Analysis
between groups revealed significant difference of DB values
on days 15 and 20 in groups BO and control (p=0,0002) and
(p=0,0046) (Figure 3).
FIGURE 3 - Direct bilirubin. Data are presented as
means ± SD. + p < 0,05 for basal (15 days)
versus group BO (15 and 20 days); * p <
0,05 for group BO(15 and 20 days) versus
group CHB (15 and 20 days); ** p < 0,05
for group BO/DB (25days) versus group
CHB (25 days);    p < 0,05  for group BO/
DB (25 days) versus group BO (20 days).
Alkaline phosphatase: Analysis within group
demonstrated in group BO significant difference between
basal value and days 15 (p=0,064) and 20 (p= 0,016). Analysis
between groups revealed significant difference of AP values
on days 15 and 20 in groups BO and control (p=0,003) and
(p=0,002) (Figure 4).
FIGURE 4 - Alkaline phosphatase. Data are presented
as means ± SD. + p < 0.05 for basal value
versus BO (15 and 20 days); ++ p<0.05 for
basal values  versus group CHB (25 days)
group; * p < 0,05  for group BO (15 and 20
days) versus group CHB (15 and 20 days);
** p < 0,05 for group BO/DB (25 days)
versus group CHB (25 days).
Portal flow: In group BO mean portal flow value
on day 15 was significantly higher than on day 0, on the
contrary, day 20 presented significantly reduced value than
day 15. In group CED, greater statistically different values
was observed for on day 20 compared to basal (Figure 5).
FIGURE 5 - Portal flow. Data are presented as means
± SD. + p < 0.05 for basal values versus
group BO (15 and 20 days); ++ p<0.05
basal value versus group CED (20 days);
+++ p=0.05 for basal value versus group
BOD/DB (25 days).
Nitric Oxide:  For NO plasma values statistical
significance was observed within group BO on days 15 and
20 compared to basal value (p= 0,032 and 0,007,
respectively). Similar results were noticed between groups
BO and control (p= 0,028 and 0,028 respectively) on days
15 and 20. Hepatic tissue did not reveal significant difference
either within or between groups (Figure 6).
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Malondialdehyde: Statistical significance was
observed between groups OB and CHB on days 15 (p=0,048)
and 20 (p=0,042) (Figure 7).
Discussion
Contrary to literature data which reports events
related to extra-hepatic cholestasis in a isolated manner, the
present experiment proposed a simultaneous study of
hepatic histological alterations and DB, AP, portal flow,
plasma and hepatic NO, and hepatic MDA by performing
biliary obstruction in rats. Results demonstrated acute
histological alterations, significant rises in DB and AP in
the occluded group, significant reduction of portal vein
flow, significant augment of plasma NO and hepatic MDA
revealing hepatic lipid peroxidation. Reduced portal flow
may be attributed to portal vein compression by intense
FIGURE 6      - Plasma NO. Data are presented as means ± SD. + p < 0,05 basal value versus group BO (15
and 20 days); * p < 0,05  for group BO (15 and 20 days) versus group CHB (15 and 20 days);
** p < 0,05 for group BO/DB (25 days) versus t=25 days in group CHB;    p < 0,05 for group
BO/DB (25 days) versus group BO (20 days). No differences in NO liver tissue.
 
biliary tree dilation, on account that on day 20 there was a
significant reduction of portal flow not correspondent to
the concomitant rise of plasma NO. Nevertheless, the
significant increase in plasma NO may imply in portal
vasodilation and consequent decline in flow. Negative
findings related to NO in the hepatic tissue, may call to
mind that the method using Griess solution chosen by this
study, must be substituted by imunohistochemistry.18,19
In a simplified manner and based on pertinent
literature, the following sequence of physiopathologic
events may be suggested:
Conclusion
Biliary obstruction results in morphologic
(histology) and functional (increases in direct bilirubin and
alkaline phosphatase) alterations of the liver, concomitant
to reduction in portal flow and increase of plasmatic NO
and hepatic tissue MDA.
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Comments:
General presentation: the manuscript entitled “ Histological liver portal flow and plasma nitric oxide alterations caused by
biliary obstruction and drainage in rats” was adequately presented and in conformity to the technical Journal rules.
Introduction/objectives: recent and coherent literature reports on the subject are mentioned in the introduction. The
objectives were to evaluate portal flux and plasma levels of nitric oxide induced by experimental biliary obstruction and
posterior drainage. Methodology: the experimental model adopted by the authors is adequate and the biochemical and
histological methods pertinent, besides employing Doppler measurements of the portal flow to meet the objectives proposed.
Results: are presented sequentially, in a clear and didactic form, showing interesting aspects of the oxidative hepatic stress
and of plasma levels of nitric oxide during the hepatic cholestasis.  In addition, data about reversibility of pathological
alterations following biliary obstruction relief are stressed by the authors. Discussion: results are argued and conclude
that experimental biliary obstruction results in decreased portal flow, increased plasma nitric oxide levels and increased
oxidative stress of the hepatic parenchyma, tending to normality after biliary drainage. Considering the above observations,
the manuscript, “ Histological liver portal flow and plasma nitric oxide level alterations caused by biliary obstruction and
drainage in rats “ should be published in Acta Cirurgica Brasileira.
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